Related Experiment Video
Updated: Jul 4, 2025

Predictive Measurement for Windlass Change in Length and Selected Treatment Outcomes in Chronic Plantar Fasciitis
Published on: March 1, 2024
A chronic non-healing ulcer plantar
Luisa Unterluggauer1, Ichiro Okamoto1
1Department of Dermatology Medical University of Vienna Vienna Austria.
This case study highlights successful immunotherapy for advanced acral melanoma. Treatment with Ipilimumab and Nivolumab achieved a complete response without surgical intervention for the primary tumor or metastases.
Area of Science:
- Oncology
- Dermatology
- Immunotherapy
Background:
- Acral melanoma presents diagnostic challenges and has a poor prognosis once metastatic.
- Therapeutic efficacy for metastatic acral melanoma is often limited compared to other melanoma types.
Purpose of the Study:
- To report a case of advanced acral melanoma.
- To describe the successful use of immunotherapy as a primary treatment modality.
Main Methods:
- Diagnosis of acral melanoma was established after distant metastases were present.
- Treatment initiated with a combination immunotherapy regimen: Ipilimumab and Nivolumab.
Main Results:
- A complete response was achieved in the patient.
- The response was obtained without the need for surgical removal of any tumors, including the primary acral melanoma.
Conclusions:
- Immunotherapy with Ipilimumab and Nivolumab can be an effective primary treatment for metastatic acral melanoma.
- Complete response is achievable without surgery in select cases of advanced acral melanoma.
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

